Delivery of Nucleotides for Gene Silencing of Cancer-Promoting Genes in Breast Cancer Cells
Date
2016-07-05
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Gene silencing through RNA interference (RNAi) is a common tool for
cancer therapy via the delivery of siRNA. While this siRNA is effective at
knocking down genes, a problem arises due to the inability of siRNA to enter
the cell cytosol on its own. Many delivery agents are cytotoxic and inefficient,
and dosing high amounts of siRNA can be toxic as well. We used nanoparticlestabilized
capsules (NPSCs) to overcome the cytotoxicity and entrapment
problems associated with common delivery agents. The gene of interest to be
knocked down was hormonally up-regulated neu-associated kinase (Hunk),
which is a gene expressed in HER2 cancer subtype, downregulates tumor
suppressors, and is involved in metastasis.
NPSCs were synthesized with anti-Hunk siRNA and/or lapatinib, a HER2
inhibitor. It was discovered that NPSCs with anti-Hunk siRNA effectively
silences Hunk, shown by expression levels post-treatment, and cell viability
decreases after treatment. Lapatinib NPSCs did not decrease Hunk expression,
but did decrease viability. In the future, studies will aim to observe lapatinib’s
effects at lower concentrations, tumor suppressor protein levels, and additive
effects of dosing with multiple siRNAs or drugs in the same capsule complex.
Description
Keywords
Nanoparticle, Nanocapsule, Gene silencing, Lapatinib, Cancer, Hunk, Arginine